Refine by
Applications
- Motor-Assisted Therapeutic Exercise Equipment for Parkinson’s Patients
- Physical Therapy Stationary Bicycle for Autism
- Solution for Ultrafast Laser Spectroscopy / Imaging
- Solution for High-Speed 4D Imaging
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Stroke
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Parkinson`s Disease
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Multiple Sclerosis
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Cerebral Palsy
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Traumatic Brain Injuries
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Spinal Cord Injuries
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Cardiac Rehabilitation & Health
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Senior Wellness
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Obesity & Weight Loss
Parkinsons Disease Equipment & Supplies
96 equipment items found
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Parkinson’s disease is a neurodegenerative disorder that affects more than 6 million people worldwide. In most cases, the exact cause of Parkinson’s disease is unknown; however, mutations in GBA1, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme, have been tied to the disease. These ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson's disease ...
Manufactured by:AnaSpec based inFremont, CALIFORNIA (USA)
Parkinson's disease is predominantly a movement disorder resulting from degeneration of dopaminergic neurons in the substantia nigra. The cause of the disease is unknown, but substantial evidence suggests that the aggregation of α-synuclein is a critical step in the etiology of Parkinson's disease (PD). ...
Manufactured by:Neuro Device Innovations (NDI) based inCleveland, OHIO (USA)
After more than a decade of research, Professor Grill's lab discovered a way to 'speak' to the area of the brain that controls movement in people with Parkinson's disease. The stimulation patterns were designed to be more effective and/or more energy efficient than standard ...
by:Pureims B.V. based inRoden, NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 years. It is the most effective, ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and depressive disorders. The program is in clinical candidate selection phase and we expect to enter IND enabling studies early in ...
Manufactured by:Valeo Pharma Inc. based inKirkland, QUEBEC (CANADA)
The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated ...
Manufactured by:Kaneka Eurogentec S.A. based inSeraing, BELGIUM
α-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in brain, specifically in ...
Manufactured by:Gerresheimer AG based inDüsseldorf, GERMANY
This belt-worn on-body drug delivery device for small-molecule drugs has been developed for our pharma partner EVER Pharma. The wearable device is used by Parkinson's disease patients for the administration of apomorphine to treat this long-term degenerative disorder of the central nervous system. This device is customizable to be used with suitable other drugs ...
Manufactured by:MagQu LLC USA based inSurprise, ARIZONA (USA)
When tau proteins become defective, It will result in the self-assembly of tangles in brain and increased some neurodegenerative diseasesincluding Alzheimer’s disease (AD)?Pick's disease?Parkinson's disease (PD)?Progressive supranuclear palsy(PSP) and Corticobasal degeneration ...
Manufactured by:Great Lakes NeuroTechnologies based inCleveland, OHIO (USA)
The KinesiaU™ motor assessment system serves as a clinically validated, cost-effective prescription application designed for individuals managing Parkinson’s disease and essential tremor. This innovative system is compatible with both iPhone and Android smartphones, as well as smartwatches, allowing users to systematically track core symptoms including tremors, ...
Manufactured by:Shanghai Siyi Intelligent Technology Co., Ltd based inShanghai, CHINA
It allows the wearer to say goodbye to cumbersomeness and uncomfortableness. In the future, it will be a life assistant for patients with stroke, spinal paralysis, arthritis, Parkinson's disease, and the ...
Manufactured by:LTS Lohmann Therapie-Systeme AG based inAndernach, GERMANY
The TTS innovations accommodate individual market positioning and lifecycle management of established products. They are well-suited for patients with special needs, including those with Parkinson’s disease, and are particularly beneficial for children, older adults, and patients with complex care requirements due to easier application and reduced dosage ...
Manufactured by:Alkahest, Inc. based inSan Carlos, CALIFORNIA (USA)
Alkahest, with its partner Grifols, is developing lead clinical candidates, GRF6019 and GRF6021, as potential treatments for neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease with cognitive impairment. Designed to safely replenish regenerative positive chronokines that decrease with age, ...
Manufactured by:ReGen Therapeutics Limited based inLondon, UNITED KINGDOM
The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral ...
Manufactured by:Manus Neurodynamica based inEdinburgh, UNITED KINGDOM
Motion features are translated into biomarkers to provide objective information about movement abnormalities which support diagnosis and monitoring of Parkinson's disease and other impairments. Full audit trail of results. Full monitoring of changes over time. Patented and CE marked as a medical device. Manufacturing setup with QMS according to all relevant ...